Dive into a conversation between Chris Mansi, CEO of Viz.ai, and Greg Meyers, Chief Digital & Technology Officer of Bristol Myers Squibb, as they discuss the transformative impact of Artificial Intelligence (AI) on the commercialization of pharmaceutical therapies. Discover how AI is reshaping patient care pathways and accelerating the deployment of therapy.
Life Sciences
Fierce Pharma: Unlocking AI’s Potential in Pharma with Greg Meyers and Chris Mansi
Wed, January 10, 2024 12:00 AM (EST)